AHEALTH | APEX HEALTHCARE BERHAD

2.51 (0.4%)
2

T-O (am): 0.000 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score
AHEALTH | APEX HEALTHCARE BERHAD

Support & Resistance

ATR Trailing Stop: 2.53

Support
Last Price
Resistance
Price 2.45 2.46 2.48 2.49 2.51 2.51 2.51 2.52 2.54 2.55 2.56
Volume (M) 0.6 4.1 10.2 3.0 1.2 1.2 0.7 1.6 1.3 1.6

Gann Support: 2.49/2.41 | Resistance: 2.57/2.65

*Highlighted column shows significant volume at the support or resistance area.

Technical Trend

Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Pivot Point

S2
S1
P
R1
R2
Daily 2.48 2.49 2.51 2.52 2.54
Weekly 2.45 2.48 2.51 2.54 2.57

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
23 Aug 23 Q2 Jun 23 2 31 Dec 23 215.03 334.52 329.48 153.2% 2.50 46.13 12.5% 2.8% 1256.9% 1302.7%
24 May 23 Q1 Mar 23 1 31 Dec 23 245.80 29.67 24.28 9.9% 0.00 5.12 11.5% 13.8% 30.3% 54.0%
22 Feb 23 Q4 Dec 22 4 31 Dec 22 220.49 40.29 34.84 15.8% 5.50 7.34 5.0% 11.6% 29.6% 68.2%
16 Nov 22 Q3 Sep 22 3 31 Dec 22 232.08 32.40 26.88 11.6% 0.00 5.67 10.9% 10.0% 14.4% 91.9%
16 Aug 22 Q2 Jun 22 2 31 Dec 22 209.25 27.85 23.49 11.2% 3.00 4.95 3.1% 14.6% 49.0% 83.2%
18 May 22 Q1 Mar 22 1 31 Dec 22 215.92 19.82 15.77 7.3% 0.00 3.33 9.2% 20.3% 23.8% 32.8%
23 Feb 22 Q4 Dec 21 4 31 Dec 21 197.66 25.30 20.70 10.5% 9.00 4.37 6.3% 22.3% 47.8% 43.8%
17 Nov 21 Q3 Sep 21 3 31 Dec 21 211.06 18.55 14.01 6.6% 0.00 2.96 15.6% 24.8% 9.2% 1.5%
19 Aug 21 Q2 Jun 21 2 31 Dec 21 182.56 16.12 12.82 7.0% 2.50 2.71 1.7% 4.5% 8.0% 1.6%
20 May 21 Q1 Mar 21 1 31 Dec 21 179.49 15.44 11.88 6.6% 0.00 2.51 11.1% 7.2% 17.5% 17.3%
25 Feb 21 Q4 Dec 20 4 31 Dec 20 161.58 18.40 14.39 8.9% 2.80 3.04 4.5% 5.3% 1.2% 2.8%
19 Nov 20 Q3 Sep 20 3 31 Dec 20 169.12 17.49 14.22 8.4% 0.00 3.01 3.2% 6.4% 9.1% 0.7%
26 Aug 20 Q2 Jun 20 2 31 Dec 20 174.73 16.34 13.03 7.5% 1.70 2.76 9.6% 9.7% 9.3% 1.4%
21 May 20 Q1 Mar 20 1 31 Dec 20 193.31 17.94 14.37 7.4% 0.00 3.05 13.3% 8.5% 2.6% 26.1%
19 Feb 20 Q4 Dec 19 4 31 Dec 19 170.63 18.48 14.00 8.2% 2.00 2.97 5.5% 4.6% 0.8% 16.7%
21 Nov 19 Q3 Sep 19 3 31 Dec 19 180.65 17.12 14.12 7.8% 0.00 3.00 13.4% 15.8% 6.8% 3.1%
21 Aug 19 Q2 Jun 19 2 31 Dec 19 159.27 16.18 13.22 8.3% 1.70 2.81 10.6% 5.4% 16.0% 0.3%
23 May 19 Q1 Mar 19 1 31 Dec 19 178.23 14.54 11.40 6.4% 0.00 9.71 9.3% 16.8% 32.2% 10.9%
28 Feb 19 Q4 Dec 18 4 31 Dec 18 163.06 16.74 16.80 10.3% 7.00 14.33 4.6% 3.4% 22.7% 49.1%
16 Aug 18 Q2 Jun 18 2 31 Dec 18 155.95 17.37 13.70 8.8% 6.50 11.69 7.4% 0.4% 3.9% 33.0%
24 May 18 Q1 Mar 18 1 31 Dec 18 168.40 16.53 13.18 7.8% 0.00 11.25 10.4% 8.9% 3.0% 30.6%
22 Feb 18 Q4 Dec 17 4 31 Dec 17 152.59 16.38 12.80 8.4% 6.50 10.93 3.3% 5.8% 13.6% 89.5%
14 Nov 17 Q3 Sep 17 3 31 Dec 17 157.73 13.30 11.27 7.2% 0.00 9.62 1.6% 10.3% 9.4% 29.0%
16 Aug 17 Q2 Jun 17 2 31 Dec 17 155.30 13.45 10.30 6.6% 5.50 8.79 0.4% 5.9% 2.0% 6.7%
17 May 17 Q1 Mar 17 1 31 Dec 17 154.65 12.91 10.09 6.5% 0.00 8.61 7.3% 4.9% 49.4% 2.8%
23 Feb 17 Q4 Dec 16 4 31 Dec 16 144.15 10.08 6.76 4.7% 6.00 5.77 0.8% 7.4% 22.7% 51.1%
15 Nov 16 Q3 Sep 16 3 31 Dec 16 142.96 11.54 8.74 6.1% 0.00 7.46 2.5% 11.4% 9.5% 62.4%
17 Aug 16 Q2 Jun 16 2 31 Dec 16 146.69 12.31 9.65 6.6% 5.50 8.24 0.5% 18.0% 1.7% 46.1%
18 May 16 Q1 Mar 16 1 31 Dec 16 147.48 12.37 9.81 6.7% 0.00 8.38 9.8% 5.3% 28.9% 16.2%
25 Feb 16 Q4 Dec 15 4 31 Dec 15 134.25 16.91 13.81 10.3% 6.00 11.79 4.7% 8.9% 156.6% 44.6%
26 Nov 15 Q3 Sep 15 3 31 Dec 15 128.27 7.72 5.38 4.2% 0.00 4.59 3.2% 4.7% 18.5% 27.4%
19 Aug 15 Q2 Jun 15 2 31 Dec 15 124.28 9.08 6.60 5.3% 5.00 5.64 11.3% 1.5% 21.8% 12.6%
20 May 15 Q1 Mar 15 1 31 Dec 15 140.06 11.88 8.45 6.0% 0.00 7.21 13.6% 7.0% 11.5% 10.8%
25 Feb 15 31/12/14 4 31/12/14 123.31 12.67 9.54 7.7% 6.00 8.13 0.7% 16.1% 28.8% 25.3%

Historical Dividends

Financial Ratios

EPS 57.86 sen
Trailing PE (Sector Median: 17.0) 4.3
PEG 0.04
Altman Z 3.6
Beaver 0.029
Current Ratio 3.91
Debt-Equity (DE) Ratio 1.0
FCF Yield 0.86 %
Revenue QoQ -12.52 %
Revenue YoY 2.76%
Profit QoQ 1256.9 %
Profit YoY 1302.71 %
Profit Margin (Sector Median: 7.4) 45.49 %
ROE (ROIC: 46.74) 46.78 %
Dividend Per Share (DPS) 8.0 sen
Dividend Yield (DY) 3.19 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 17.0)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 7.4)
ROE (ROIC: 46.66)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 3 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 1.24
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 329.48
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 243.8
Expected Revenue (M) 2021.55
Expected Growth (%) 17.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


MR KEE KIRK CHUEN added 75000.0 units announced on 20 Sep 2023 at ~RM2.48

DR KEE KIRK CHIN added 75000.0 units announced on 20 Sep 2023 at ~RM2.48

MR KEE KIRK CHUEN added 114000.0 units announced on 13 Jul 2023 at ~RM2.39

DR KEE KIRK CHIN added 114000.0 units announced on 13 Jul 2023 at ~RM2.39

MR KEE KIRK CHUEN added 74000.0 units announced on 01 Jun 2023 at ~RM3.87

DR KEE KIRK CHIN added 74000.0 units announced on 01 Jun 2023 at ~RM3.87

MR LEONG KHAI CHEONG added 81600.0 units announced on 17 Oct 2022 at ~RM3.11

DR KEE KIRK CHIN added 10000.0 units announced on 17 Oct 2022 at ~RM3.11

MR KEE KIRK CHUEN added 10000.0 units announced on 17 Oct 2022 at ~RM3.11

MR KEE KIRK CHUEN added 172200.0 units announced on 14 Oct 2022 at ~RM3.06

DR KEE KIRK CHIN added 172200.0 units announced on 14 Oct 2022 at ~RM3.06

DR KEE KIRK CHIN added 23400.0 units announced on 29 Sep 2022 at ~RM3.16

MR KEE KIRK CHUEN added 23400.0 units announced on 29 Sep 2022 at ~RM3.16

MR KEE KIRK CHUEN added 29000.0 units announced on 19 Sep 2022 at ~RM3.19

DR KEE KIRK CHIN added 29000.0 units announced on 19 Sep 2022 at ~RM3.19

MR KEE KIRK CHUEN added 30000.0 units announced on 14 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 44000.0 units announced on 12 Jul 2022 at ~RM2.92

DR KEE KIRK CHIN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR KEE KIRK CHUEN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 76000.0 units announced on 08 Jul 2022 at ~RM2.9

MR ROBERT DOBSON MILLNER added 80000.0 units announced on 07 Jul 2022 at ~RM2.85

MR KEE KIRK CHUEN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

DR KEE KIRK CHIN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

MR KEE KIRK CHUEN added 30000.0 units announced on 13 Dec 2021 at ~RM2.57

DR KEE KIRK CHIN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 50000.0 units announced on 12 Mar 2021 at ~RM2.87

MR KEE KIRK CHUEN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

DR KEE KIRK CHIN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

Summary


Market Cap: 1802 M.

Number of Shares: 718 M.

Adjusted Float: 30.5%.

Stock highly correlated with

CHINHIN (95%)

YNHPROP (95%)

TIMECOM (94%)

AYER (92%)

Apex Healthcare Berhad is an investment holding company. The company is engaged in the development, manufacturing, wholesaling, marketing, and distribution of pharmaceuticals, consumer healthcare products, and medical devices. For example range of products in the manufacturing segment include cough mixtures and antihistamines, anti-infectives, anti-diabetics, anti-hypertensives, neuromuscular agents, analgesics, dermatological and ophthalmological in the form of tablets, capsules, oral liquid, and suspension, creams, and sterile eyedrops. The company is also one of the distributors for internationally famous brands such as Nestle, 3M, and Rigel Pharma. It has direct operations in Malaysia, Singapore, Vietnam, and Myanmar. The company was founded in 1962 and is headquartered in Melaka, Malaysia.

Sectors: Pharmaceuticals, Healthcare, Vaccine

Code: 7090

Website: http://www.apexhealthcare.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 15-Mar-2023

Shareholder Value (M)
Apex Pharmacy Holdings Sendirian Bhd 477.67
Washington H.Soul Pattinson and Company Ltd 355.97
Lim Teh Realty Sdn Bhd 16.31
Public Islamic Opportunities Fund 12.23
Md Ali bin Md Dewal 12.11
Xepa Holdings Sdn Bhd 11.27
Liew Yoon Yee 10.07
Tan Su-Ann 10.07
DBS Bank Ltd 9.59
Icapital.biz Bhd 9.47
Public Strategic Smallcap Fund 7.55
Apex Holdings (PTE) Ltd 6.47
Chan Heng Koon 6.23
Teoh Choon Neo @ Ivy Teoh Choon Neo 5.76
Public Focus Select Fund 5.76
Singam a/l Kumarasamy 5.52
Yeo Lee Hee 4.68
PB Islamic Smallcap Fund 4.56
Wong Yee Hui 4.08
Oh Siew Heong 3.96
Manulife Investment Progress Fund 3.84
Tan Jin Thai 3.72
Kee Kirk Chin 3.72
Susy Ding 3.36
Leong Wai Kuen 3.24
Phua Kiap Wite 2.88
Rastam Dewal bin Md Ali 2.76
Leong Khai Cheong 2.76

This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.